{
  "trial_id": "NCT02515630",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, baseline hemoglobin level, baseline platelet count, baseline white blood cell count, baseline spleen size, baseline liver size, prior myelofibrosis therapy, dynamic international prognostic scoring system (DIPSS) risk category, baseline transfusion requirement, baseline serum creatinine, baseline AST/SGOT, baseline ALT/SGPT, baseline direct bilirubin, life expectancy, presence of peripheral neuropathy, prior splenectomy, prior splenic irradiation, prior treatment with Janus kinase (JAK) inhibitors, HIV status, hepatitis status, use of CYP3A4 inducers.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "RBC Units Transfused within 8 weeks prior to Enrollment",
          "baseline transfusion requirement"
        ],
        [
          "Platelets",
          "baseline platelet count"
        ],
        [
          "Spleen Volume",
          "baseline spleen size"
        ],
        [
          "Liver Iron Content",
          "baseline liver size"
        ],
        [
          "Hemoglobin",
          "baseline hemoglobin level"
        ],
        [
          "Leukocytes",
          "baseline white blood cell count"
        ],
        [
          "Aspartate aminotransferase (AST/SGOT)",
          "baseline AST/SGOT"
        ],
        [
          "Alanine aminotransferase (ALT/SGPT)",
          "baseline ALT/SGPT"
        ],
        [
          "Direct bilirubin",
          "baseline direct bilirubin"
        ],
        [
          "Serum creatinine",
          "baseline serum creatinine"
        ],
        [
          "Life expectancy",
          "life expectancy"
        ],
        [
          "Presence of peripheral neuropathy",
          "presence of peripheral neuropathy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Total Symptom Score",
        "Hepcidin",
        "Serum iron",
        "Total iron binding capacity",
        "Reticulocytes",
        "Reticulocytes/erythrocytes",
        "Erythropoietin",
        "Erythrocytes",
        "Hematocrit",
        "Ferritin",
        "Soluble transferrin receptor",
        "Transferrin saturation",
        "Unsaturated iron binding capacity",
        "Blasts",
        "%pSTAT Stimulated CD3+/4+ T cell",
        "%pSTAT %tSTAT Stimulated CD3+/4+ T cell Ratio",
        "C-Reactive Protein"
      ],
      "remaining_candidate_features": [
        "prior myelofibrosis therapy",
        "dynamic international prognostic scoring system (DIPSS) risk category",
        "prior splenectomy",
        "prior splenic irradiation",
        "prior treatment with Janus kinase (JAK) inhibitors",
        "HIV status",
        "hepatitis status",
        "use of CYP3A4 inducers"
      ]
    },
    "processed-gen-response": "Age, gender, race, baseline hemoglobin level, baseline platelet count, baseline white blood cell count, baseline spleen size, baseline liver size, prior myelofibrosis therapy, dynamic international prognostic scoring system (DIPSS) risk category, baseline transfusion requirement, baseline serum creatinine, baseline AST/SGOT, baseline ALT/SGPT, baseline direct bilirubin, life expectancy, presence of peripheral neuropathy, prior splenectomy, prior splenic irradiation, prior treatment with Janus kinase (JAK) inhibitors, HIV status, hepatitis status, use of CYP3A4 inducers."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Platelet Count, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Serum Creatinine, Direct Bilirubin, Transfusion Dependence at Baseline, DIPSS Risk Category, Spleen Size, Liver Size,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Platelets",
          "Platelet Count"
        ],
        [
          "Aspartate aminotransferase (AST/SGOT)",
          "Aspartate Aminotransferase (AST)"
        ],
        [
          "Alanine aminotransferase (ALT/SGPT)",
          "Alanine Aminotransferase (ALT)"
        ],
        [
          "Serum creatinine",
          "Serum Creatinine"
        ],
        [
          "Direct bilirubin",
          "Direct Bilirubin"
        ],
        [
          "RBC Units Transfused within 8 weeks prior to Enrollment",
          "Transfusion Dependence at Baseline"
        ],
        [
          "Spleen Volume",
          "Spleen Size"
        ]
      ],
      "remaining_reference_features": [
        "Hepcidin",
        "Serum iron",
        "Hemoglobin",
        "Total iron binding capacity",
        "Reticulocytes",
        "Reticulocytes/erythrocytes",
        "Erythropoietin",
        "Erythrocytes",
        "Hematocrit",
        "Ferritin",
        "Soluble transferrin receptor",
        "Transferrin saturation",
        "Unsaturated iron binding capacity",
        "Leukocytes",
        "Blasts",
        "Liver Iron Content",
        "%pSTAT Stimulated CD3+/4+ T cell",
        "%pSTAT %tSTAT Stimulated CD3+/4+ T cell Ratio",
        "C-Reactive Protein"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "DIPSS Risk Category",
        "Liver Size"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Platelet Count, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Serum Creatinine, Direct Bilirubin, Transfusion Dependence at Baseline, DIPSS Risk Category, Spleen Size, Liver Size"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diagnosis (PMF, Post-PV/ET MF), DIPSS Risk Category, Transfusion dependence at baseline, Platelet Count, AST/SGOT, ALT/SGPT, Serum creatinine, Direct bilirubin, Life expectancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "RBC Units Transfused within 8 weeks prior to Enrollment",
          "Transfusion dependence at baseline"
        ],
        [
          "Platelets",
          "Platelet Count"
        ],
        [
          "AST/SGOT",
          "AST/SGOT"
        ],
        [
          "ALT/SGPT",
          "ALT/SGPT"
        ],
        [
          "Serum creatinine",
          "Serum creatinine"
        ],
        [
          "Direct bilirubin",
          "Direct bilirubin"
        ]
      ],
      "remaining_reference_features": [
        "Spleen Volume",
        "Total Symptom Score",
        "Hepcidin",
        "Serum iron",
        "Hemoglobin",
        "Total iron binding capacity",
        "Reticulocytes",
        "Reticulocytes/erythrocytes",
        "Erythropoietin",
        "Erythrocytes",
        "Hematocrit",
        "Ferritin",
        "Soluble transferrin receptor",
        "Transferrin saturation",
        "Unsaturated iron binding capacity",
        "Leukocytes",
        "Blasts",
        "Liver Iron Content",
        "%pSTAT Stimulated CD3+/4+ T cell",
        "%pSTAT %tSTAT Stimulated CD3+/4+ T cell Ratio",
        "C-Reactive Protein"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diagnosis (PMF, Post-PV/ET MF)",
        "DIPSS Risk Category",
        "Life expectancy."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diagnosis (PMF, Post-PV/ET MF), DIPSS Risk Category, Transfusion dependence at baseline, Platelet Count, AST/SGOT, ALT/SGPT, Serum creatinine, Direct bilirubin, Life expectancy."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), diagnosis (PMF or Post-PV/ET MF), DIPSS risk category, presence of symptomatic splenomegaly and/or hepatomegaly, platelet count, AST/SGOT, ALT/SGPT, serum creatinine, direct bilirubin, life expectancy, prior therapies, comorbidities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Platelets",
          "platelet count"
        ],
        [
          "Aspartate aminotransferase (AST/SGOT)",
          "AST/SGOT"
        ],
        [
          "Alanine aminotransferase (ALT/SGPT)",
          "ALT/SGPT"
        ],
        [
          "Serum creatinine",
          "serum creatinine"
        ],
        [
          "Direct bilirubin",
          "direct bilirubin"
        ],
        [
          "Life expectancy",
          "life expectancy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Spleen Volume",
        "Total Symptom Score",
        "RBC Units Transfused within 8 weeks prior to Enrollment",
        "Hepcidin",
        "Serum iron",
        "Hemoglobin",
        "Total iron binding capacity",
        "Reticulocytes",
        "Reticulocytes/erythrocytes",
        "Erythropoietin",
        "Erythrocytes",
        "Hematocrit",
        "Ferritin",
        "Soluble transferrin receptor",
        "Transferrin saturation",
        "Unsaturated iron binding capacity",
        "Leukocytes",
        "Blasts",
        "Liver Iron Content",
        "%pSTAT Stimulated CD3+/4+ T cell",
        "%pSTAT %tSTAT Stimulated CD3+/4+ T cell Ratio",
        "C-Reactive Protein"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "weight",
        "height",
        "body mass index (BMI)",
        "diagnosis (PMF or Post-PV/ET MF)",
        "DIPSS risk category",
        "presence of symptomatic splenomegaly and/or hepatomegaly",
        "prior therapies",
        "comorbidities"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), diagnosis (PMF or Post-PV/ET MF), DIPSS risk category, presence of symptomatic splenomegaly and/or hepatomegaly, platelet count, AST/SGOT, ALT/SGPT, serum creatinine, direct bilirubin, life expectancy, prior therapies, comorbidities."
  }
}